6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10743 | CDK9-IN-11 | CDK | |
CDK9-IN-11 is a potent CDK9 inhibitor that is the ligand for the PROTAC CDK9 Degrader-1 [1]. | |||
T10745 | CDK9-IN-7 | CDK | |
CDK9-IN-7 is a highly selective and orally active CDK9/cyclin T inhibitor (IC50: 11 nM), which exhibits more potent over other CDKs (CDK4/cyclinD: 148 nM; CDK6/cyclinD: 145 nM). | |||
T62203 | CDK9-IN-14 | ||
CDK9-IN-14 is a potent, high and low selective CDK9 inhibitor (IC50: 6.92 nM). CDK9-IN-14 is a strong inhibitor of MV-4-11 cells and in vivo tumour models with low toxicity and few side effects. | |||
T63490 | CDK9-IN-19 | ||
CDK9-IN-19 is a selective and potent CDK9 inhibitor (IC50: 2.0 nM). CDK9-IN-19 exhibits good anti-proliferative activity in cancer cells, moderate pharmacokinetic properties and low hERG inhibition. CDK9-IN-19 significan... | |||
T69197 | AG-012986 HCl | ||
AG-012986 HCl is a multitargeted CDK inhibitor active against CDK1, CDK2, CDK4/6, CDK5, and CDK9, with selectivity over a diverse panel of non-CDK kinases. | |||
T69196 | AG-012986 | ||
AG-012986 is a multitargeted CDK inhibitor active against CDK1, CDK2, CDK4/6, CDK5, and CDK9, with selectivity over a diverse panel of non-CDK kinases. |